Literature DB >> 16688832

Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey.

Giorgio Nervi1, Stefania Liatopoulou, Lucas-Giovanni Cavallaro, Alessandro Gnocchi, Nadia Dal-Bo, Massimo Rugge, Veronica Iori, Giulia-Martina Cavestro, Marta Maino, Giancarlo Colla, Angelo Franze, Francesco Di Mario.   

Abstract

AIM: To compare peptic ulcer prevalence in patients referred for upper gastrointestinal endoscopy in two Italian hospitals in pre-Helicobacter era and ten years after the progressive diffusion of eradication therapy.
METHODS: We checked all the endoscopic examinations consecutively performed in the Gastroenterology Unit of Padova during 1986-1987 and 1995-1996, and in the Gastroenterology Unit of Parma during 1992 and 2002. Chi Square test was used for statistic analysis.
RESULTS: Data from both the endoscopic centers showed a statistically significant decrease in the prevalence of ulcers: from 12.7% to 6.3% (P<0.001) in Padova and from 15.6% to 12% (P<0.001) in Parma. The decrease was significant both for duodenal (from 8.8% to 4.8%, P<0.001) and gastric ulcer (3.9% to 1.5%, P<0.001) in Padova, and only for duodenal ulcer in Parma (9.2% to 6.1%, P<0.001; gastric ulcer: 6.3% to 5.8%, NS).
CONCLUSION: Ten years of extensive Helicobacter pylori (H pylori) eradication in symptomatic patients led to a significant reduction in peptic ulcer prevalence. This reduction was particularly evident in Padova, where a project for the sensibilization of H pylori eradication among general practioners was carried out between 1990 and 1992. Should our hypothesis be true, H pylori eradication might in the future lead to peptic ulcer as a rare endoscopic finding.

Entities:  

Mesh:

Year:  2006        PMID: 16688832      PMCID: PMC4088077          DOI: 10.3748/wjg.v12.i15.2398

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Authors:  R W Van der Hulst; E A Rauws; B Köycü; J J Keller; M J Bruno; J G Tijssen; G N Tytgat
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

Review 3.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

Authors:  A Ford; B Delaney; D Forman; P Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

4.  Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.

Authors:  H H Xia; N Phung; E Altiparmak; A Berry; M Matheson; N J Talley
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

5.  Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000.

Authors:  M E van Leerdam; E M Vreeburg; E A J Rauws; A A M Geraedts; J G P Tijssen; J B Reitsma; G N J Tytgat
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

6.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

7.  The impact of Helicobacter pylori eradication on peptic ulcer healing.

Authors:  G Treiber; J R Lambert
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

  7 in total
  10 in total

1.  Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains.

Authors:  Li-Hui Wang; Hong Cheng; Fu-Lian Hu; Jiang Li
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Helicobacter pylori in immigrants: a "foreign" bacterium?

Authors:  Angelo Zullo; Francesca Cristofari; Maria Consiglia Bragazzi; Cesare Hassan
Journal:  Intern Emerg Med       Date:  2010-11-20       Impact factor: 3.397

3.  Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population.

Authors:  Luigi Gatta; Francesco Di Mario; Dino Vaira; Angelo Franzé; Massimo Rugge; Alberto Pilotto; Paolo Lucarini; Maurizio Lera; Giulia Fiorini; Valentina Castelli; Enkleda Kajo; Carmelo Scarpignato
Journal:  Intern Emerg Med       Date:  2010-08-19       Impact factor: 3.397

4.  Changing disease incidence: the consulting room perspective.

Authors:  Douglas M Fleming; Alex J Elliot
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

5.  Managing dyspepsia in a primary care setting.

Authors:  A Kenneth Musana; Steven H Yale; Kevin A Lang
Journal:  Clin Med Res       Date:  2006-12

6.  In vitro bactericidal activity of Jinghua Weikang Capsule and its individual herb Chenopodium ambrosioides L. against antibiotic-resistant Helicobacter pylori.

Authors:  Wei Liu; Yu Liu; Xue-Zhi Zhang; Ning Li; Hong Cheng
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

7.  Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection.

Authors:  Hui-Chao Wu; Bi-Guang Tuo; Wei-Min Wu; Yuan Gao; Qing-Qing Xu; Kui Zhao
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

8.  Helicobacter pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years.

Authors:  Vincenzo De Francesco; Marcella Margiotta; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Mariangela Zotti; Giuseppe Stoppino; Alessia Bastianelli; Francesco Diterlizzi; Giovanna Verderosa; Sergio Morini; Carmine Panella; Enzo Ierardi
Journal:  Dig Dis Sci       Date:  2008-07-03       Impact factor: 3.199

9.  Endoscopic and histopathologic findings associated with H. pylori infection in very young children.

Authors:  Engin Tutar; Deniz Ertem; Esin Kotiloglu Karaa; Ender Pehlivanoglu
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

10.  In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.

Authors:  Qian Rong; Min Xu; Qi Dong; Yuli Zhang; Yinglun Li; Gang Ye; Ling Zhao
Journal:  BMC Complement Altern Med       Date:  2016-08-30       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.